Enveric Biosciences, Inc. (ENVB) Operating cash flow 2016–2025
Enveric Biosciences, Inc. (ENVB) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$8.1MFY2025 · since FY2016: -$2.7M → -$8.1M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$8.1M | -5.4% |
| FY2024 | -$7.7M | +45.2% |
| FY2023 | -$14.1M | +17.8% |
| FY2022 | -$17.1M | -49.7% |
| FY2021 | -$11.5M | -194.6% |
| FY2020 | -$3.9M | -500.3% |
| FY2019 | -$647,860 | +74.7% |
| FY2018 | -$2.6M | +6.4% |
| FY2017 | -$2.7M | -1.4% |
| FY2016 | -$2.7M | — |
Source: SEC XBRL filings · For reference only · Not investment advice